Sarepta Therapeutics (SRPT) Revenue & Revenue Breakdown
Sarepta Therapeutics Revenue Highlights
Latest Revenue (Y)
$1.24B
Latest Revenue (Q)
$362.93M
Main Geography (Y)
UNITED STATES
Sarepta Therapeutics Revenue by Period
Sarepta Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $1.24B | 33.26% |
| 2022-12-31 | $933.01M | 32.93% |
| 2021-12-31 | $701.89M | 29.96% |
| 2020-12-31 | $540.10M | 41.82% |
| 2019-12-31 | $380.83M | 26.51% |
| 2018-12-31 | $301.03M | 94.74% |
| 2017-12-31 | $154.58M | 2751.58% |
| 2016-12-31 | $5.42M | 332.64% |
| 2015-12-31 | $1.25M | -87.16% |
| 2014-12-31 | $9.76M | -31.38% |
| 2013-12-31 | $14.22M | -61.91% |
| 2012-12-31 | $37.33M | -20.56% |
| 2011-12-31 | $46.99M | 59.72% |
| 2010-12-31 | $29.42M | 67.30% |
| 2009-12-31 | $17.59M | -17.28% |
| 2008-12-31 | $21.26M | 93.52% |
| 2007-12-31 | $10.99M | 9428.23% |
| 2006-12-31 | $115.29K | -97.59% |
| 2005-12-31 | $4.78M | 1011.31% |
| 2004-12-31 | $430.46K | -55.62% |
| 2003-12-31 | $969.87K | 15.90% |
| 2002-12-31 | $836.78K | 18.51% |
| 2001-12-31 | $706.10K | -45.57% |
| 2000-12-31 | $1.30M | 1197.34% |
| 1999-12-31 | $100.00K | -50.00% |
| 1998-12-31 | $200.00K | 100.00% |
| 1997-12-31 | $100.00K | - |
| 1996-12-31 | $100.00K | - |
| 1995-12-31 | $100.00K | - |
Sarepta Therapeutics generated $1.24B in revenue during NA 2023, up 33.26% compared to the previous quarter, and up 413.02% compared to the same period a year ago.
Sarepta Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $362.93M | -12.22% |
| 2024-03-31 | $413.46M | 4.20% |
| 2023-12-31 | $396.78M | 19.58% |
| 2023-09-30 | $331.82M | 27.02% |
| 2023-06-30 | $261.24M | 3.05% |
| 2023-03-31 | $253.50M | -1.91% |
| 2022-12-31 | $258.43M | 12.23% |
| 2022-09-30 | $230.27M | -1.38% |
| 2022-06-30 | $233.49M | 10.75% |
| 2022-03-31 | $210.83M | 4.65% |
| 2021-12-31 | $201.46M | 6.36% |
| 2021-09-30 | $189.41M | 15.43% |
| 2021-06-30 | $164.09M | 11.68% |
| 2021-03-31 | $146.93M | 1.24% |
| 2020-12-31 | $145.14M | 0.84% |
| 2020-09-30 | $143.92M | 4.78% |
| 2020-06-30 | $137.36M | 20.84% |
| 2020-03-31 | $113.67M | 13.55% |
| 2019-12-31 | $100.11M | 1.08% |
| 2019-09-30 | $99.04M | 4.62% |
| 2019-06-30 | $94.67M | 8.80% |
| 2019-03-31 | $87.01M | 3.08% |
| 2018-12-31 | $84.42M | 7.55% |
| 2018-09-30 | $78.49M | 6.74% |
| 2018-06-30 | $73.53M | 13.81% |
| 2018-03-31 | $64.60M | 12.79% |
| 2017-12-31 | $57.28M | 24.64% |
| 2017-09-30 | $45.95M | 31.26% |
| 2017-06-30 | $35.01M | 114.24% |
| 2017-03-31 | $16.34M | 201.46% |
| 2016-12-31 | $5.42M | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | -100.00% |
| 2015-12-31 | $1.25M | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2015-03-31 | - | -100.00% |
| 2014-12-31 | $27.00K | -97.45% |
| 2014-09-30 | $1.06M | -59.00% |
| 2014-06-30 | $2.58M | -57.57% |
| 2014-03-31 | $6.09M | 131.84% |
| 2013-12-31 | $2.63M | -37.00% |
| 2013-09-30 | $4.17M | 41.24% |
| 2013-06-30 | $2.95M | -34.04% |
| 2013-03-31 | $4.47M | -39.01% |
| 2012-12-31 | $7.34M | -3.14% |
| 2012-09-30 | $7.57M | -32.42% |
| 2012-06-30 | $11.21M | -0.04% |
| 2012-03-31 | $11.21M | -17.47% |
| 2011-12-31 | $13.59M | 80.56% |
| 2011-09-30 | $7.52M | -35.05% |
| 2011-06-30 | $11.59M | -18.96% |
| 2011-03-31 | $14.30M | -7.87% |
| 2010-12-31 | $15.52M | 78.32% |
| 2010-09-30 | $8.70M | 117.71% |
| 2010-06-30 | $4.00M | 231.70% |
| 2010-03-31 | $1.21M | -76.56% |
| 2009-12-31 | $5.14M | -19.03% |
| 2009-09-30 | $6.35M | 115.59% |
| 2009-06-30 | $2.94M | -6.51% |
| 2009-03-31 | $3.15M | -42.52% |
| 2008-12-31 | $5.48M | 5.98% |
| 2008-09-30 | $5.17M | 3.77% |
| 2008-06-30 | $4.98M | -11.41% |
| 2008-03-31 | $5.62M | 8.45% |
| 2007-12-31 | $5.19M | - |
Sarepta Therapeutics generated $362.93M in revenue during Q2 2024, up -12.22% compared to the previous quarter, and up 143.17% compared to the same period a year ago.
Sarepta Therapeutics Revenue Breakdown
Sarepta Therapeutics Revenue Breakdown by Product
Quarterly Revenue by Product
| Product/Service | Sep 21 | Jun 21 | Mar 21 |
|---|---|---|---|
| V Y O N D Y S Fifty Three | $24.66M | $22.44M | $17.55M |
| A M O N D Y S Fourty Five | $26.66M | $6.94M | $193.00K |
| E X O N D Y S Fifty One | $115.60M | $112.46M | $107.19M |
Sarepta Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Sep 21: E X O N D Y S Fifty One (69.26%), A M O N D Y S Fourty Five (15.97%), and V Y O N D Y S Fifty Three (14.77%).
Sarepta Therapeutics Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 |
|---|---|---|
| UNITED STATES | $797.94M | $747.10M |
| Rest of World | $146.58M | - |
| Non-US | - | $96.70M |
Sarepta Therapeutics's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (84.48%), and Rest of World (15.52%).
Quarterly Revenue by Country
| Country | Sep 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 |
|---|---|---|---|---|---|---|
| Rest of World | $38.10M | $35.88M | $104.43M | $42.15M | - | - |
| UNITED STATES | $210.68M | $189.67M | $195.47M | $198.07M | $203.90M | $200.50M |
| Non-US | - | - | - | - | $35.10M | $31.00M |
Sarepta Therapeutics's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (84.68%), and Rest of World (15.32%).
Sarepta Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| SRPT | Sarepta Therapeutics | $1.24B | $362.93M |
| PTCT | PTC Therapeutics | $937.82M | $135.42M |
| KRYS | Krystal Biotech | $50.70M | $83.84M |
| IOVA | Iovance Biotherapeutics | $1.19M | $58.55M |
| VKTX | Viking Therapeutics | - | - |
| MDGL | Madrigal Pharmaceuticals | - | $62.17M |
| TERN | Terns Pharmaceuticals | - | - |
| AKRO | Akero Therapeutics | - | - |
| HEPA | Hepion Pharmaceuticals | - | - |